ONC: BeOne Medicines Ltd. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 16 sales totaling $22.63M in the last 180 days.
Insider sales
| Trade date | Insider | Role | Value | 10b5-1 plan |
|---|---|---|---|---|
| 2026-10-13 | Wang Xiaodong | Director | $2.51M | yes |
| 2026-10-13 | Wang Xiaodong | Director | $3.63M | yes |
| 2026-10-13 | Wang Xiaodong | Director | $2.00M | yes |
| 2026-10-13 | Wang Xiaodong | Director | $2.31M | yes |
| 2026-10-13 | Wang Xiaodong | Director | $445K | yes |
| 2026-09-30 | Lee Chan Henry | Officer | $418K | yes |
| 2026-09-28 | Wang Xiaodong | Director | $57K | yes |
| 2026-09-28 | Wang Xiaodong | Director | $43K | yes |
| 2026-09-28 | Wang Xiaodong | Director | $14K | yes |
| 2026-09-28 | Wang Xiaodong | Director | $809K | yes |
| 2026-09-28 | Wang Xiaodong | Director | $1.54M | yes |
| 2026-09-28 | Wang Xiaodong | Director | $1.27M | yes |
| 2026-09-28 | Wang Xiaodong | Director | $1.24M | yes |
| 2026-09-28 | Wang Xiaodong | Director | $749K | yes |
| 2026-09-28 | Wang Xiaodong | Director | $5.32M | yes |
| 2026-09-28 | Wang Xiaodong | Director | $271K | yes |
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-09-16 | 13D amendment | Baker Bros. Advisors LP | 7.80% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.